Skip to main content

Table 2 Analysis of clinical factors for the risk of re-genome biopsy in TBB samples

From: Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study

Variables

 

Univariate

 

n = 236 (%)

OR (95% CI)

P

Age, ys

< 75

(77.1)

1

reference

≥75

(22.9)

0.648 (0.212–1.980)

0.447

Sex

Male

(60.6)

1

reference

Female

(39.4)

2.360 (0.999–5.560)

0.050

Histology

Adenocartinoma

(67.8)

1

reference

Others

(32.2)

1.580 (0.667–3.740)

0.298

Tumor location.1

Peripheral

(70.8)

1

reference

Central

(29.2)

16.60 (5.430–51.00)

< 0.0001

Tumor location.2

Right Upper and Middle/ Lower

(50.9)

1

reference

Left Upper/ Lower

(49.1)

1.630 (0.692–3.830)

0.264

Maximum diameter of tumor.(mm) [range]

39.5 [14.7–102.3]

(100.0)

1.010 (0.983–1.030)

0.658

  1. OR odds ratio, TBB transbronchial biopsy